| 臺大學術典藏 |
2020-07-21T06:25:18Z |
Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy
|
Yang P.-C.; Shih J.-Y.; Yang J.C.H.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; Jan I.-S.; Chen K.-Y.; Wang J.-Y.; Ruan S.-Y.; Yang C.-Y.; TZU-HSIU TSAI |
| 臺大學術典藏 |
2020-07-21T06:25:17Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Yang J.C.-H.; Thress K.S.; Huang D.D.-R.; Lin C.-C.;Shih J.-Y.;Yu C.-J.;Ho C.-C.;Liao W.-Y.;Lee J.-H.;Tzu-Hsiu Tsai;Su K.-Y.;Hsieh M.-S.;Chang Y.-L.;Bai Y.-Y.;Huang D.D.-R.;Thress K.S.;Yang J.C.-H.; Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; Lee J.-H.; TZU-HSIU TSAI; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y. |
| 臺大學術典藏 |
2020-07-21T06:25:17Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Liao W.-Y.; Ho C.-C.; Liao B.-C.; Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Ho C.-C.;Liao W.-Y.;Chen K.-Y.;Tzu-Hsiu Tsai;Hsu C.-L.;Hsu W.-H.;Su K.-Y.;Chang Y.-L.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Yang J.C.; Yu C.-J.; Shih J.-Y.; Lin C.-C.; Lee J.-H.; Chang Y.-L.; Su K.-Y.; Hsu W.-H.; Hsu C.-L.; TZU-HSIU TSAI; Chen K.-Y. |
| 臺大學術典藏 |
2020-07-21T06:25:17Z |
Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion
|
Tzu-Hsiu Tsai;Wu S.-G.;Hsieh M.-S.;Yu C.-J.;Yang J.C.H.;Shih J.-Y.; TZU-HSIU TSAI; Wu S.-G.; Hsieh M.-S.; Yu C.-J.; Yang J.C.H.; Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:25:17Z |
IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer
|
Shih J.-Y.; Liu Y.-N.;Chang T.-H.;Tsai M.-F.;Wu S.-G.;Tzu-Hsiu Tsai;Chen H.-Y.;Yu S.-L.;Yang J.C.-H.;Shih J.-Y.; Liu Y.-N.; Chang T.-H.; Tsai M.-F.; Wu S.-G.; TZU-HSIU TSAI; Chen H.-Y.; Yu S.-L.; Yang J.C.-H. |
| 臺大學術典藏 |
2020-07-21T06:25:16Z |
The value of radial endobronchial ultrasound-guided bronchial brushing in peripheral non-squamous non-small cell lung cancer
|
Yu K.-L.;Tzu-Hsiu Tsai;Ho C.-C.;Liao W.-Y.;Lin C.-K.;Hsu C.-L.;Shih J.-Y.; Yu K.-L.; TZU-HSIU TSAI; Ho C.-C.; Liao W.-Y.; Lin C.-K.; Hsu C.-L.; Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:25:16Z |
Oncogenic Function of a KIF5B-MET Fusion Variant in Non-Small Cell Lung Cancer
|
Shih J.-Y.; Gow C.-H.;Liu Y.-N.;Li H.-Y.;Hsieh M.-S.;Chang S.-H.;Luo S.-C.;Tzu-Hsiu Tsai;Chen P.-L.;Tsai M.-F.;Shih J.-Y.; Gow C.-H.; Liu Y.-N.; Li H.-Y.; Hsieh M.-S.; Chang S.-H.; Luo S.-C.; TZU-HSIU TSAI; Chen P.-L.; Tsai M.-F. |
| 臺大學術典藏 |
2020-07-21T06:25:16Z |
Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum
|
Liao W.-Y.;Ho C.-C.;Tzu-Hsiu Tsai;Chen K.-Y.;Shih J.-Y.;Yu C.-J.; Liao W.-Y.; Ho C.-C.; TZU-HSIU TSAI; Chen K.-Y.; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:25:15Z |
Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors
|
Shih J.-Y.; Liao W.-Y.; Lee J.-H.;Chen H.-Y.;Hsu F.-M.;Chen J.-S.;Liao W.-Y.;Shih J.-Y.;Yu C.-J.;Chen K.-Y.;Tzu-Hsiu Tsai;Yang J.C.-H.; Lee J.-H.; Chen H.-Y.; Hsu F.-M.; Chen J.-S.; Yang J.C.-H.; Yu C.-J.; Chen K.-Y.; TZU-HSIU TSAI |
| 臺大學術典藏 |
2020-07-21T06:25:15Z |
Acquired resistance to EGFR tyrosine kinase inhibitors is mediated by the reactivation of STC2/JUN/AXL signaling in lung cancer
|
Liu Y.-N.;Tsai M.-F.;Wu S.-G.;Chang T.-H.;Tzu-Hsiu Tsai;Gow C.-H.;Chang Y.-L.;Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; Wu S.-G.; Chang T.-H.; TZU-HSIU TSAI; Gow C.-H.; Chang Y.-L.; Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:25:14Z |
Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer
|
TZU-HSIU TSAI; Wu S.-G.; Liu Y.-N.; Yu C.-J.; Shih J.-Y.; Lin Y.-T.; Lin Y.-T.;Tzu-Hsiu Tsai;Wu S.-G.;Liu Y.-N.;Yu C.-J.;Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:09:14Z |
Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy
|
Tsai T.-H.;Yang C.-Y.;Ho C.-C.;Wei-Yu Liao;Jan I.-S.;Chen K.-Y.;Wang J.-Y.;Ruan S.-Y.;Yu C.-J.;Yang J.C.H.;Yang P.-C.;Shih J.-Y.; Tsai T.-H.; Yang C.-Y.; Ho C.-C.; WEI-YU LIAO; Jan I.-S.; Chen K.-Y.; Wang J.-Y.; Ruan S.-Y.; Yu C.-J.; Yang J.C.H.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:09:14Z |
Survival of lung adenocarcinoma patients with malignant pleural effusion
|
Wu S.-G.;Yu C.-J.;Tsai M.-F.;Wei-Yu Liao;Yang C.-H.;Jan I.-S.;Yang P.-C.;Shih J.-Y.; Wu S.-G.; Yu C.-J.; Tsai M.-F.; WEI-YU LIAO; Yang C.-H.; Jan I.-S.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:09:14Z |
Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer
|
Wei-Yu Liao;Chen J.-H.;Wu M.;Shih J.-Y.;Chen K.-Y.;Ho C.-C.;Yang J.C.-H.;Yu C.-J.; WEI-YU LIAO; Chen J.-H.; Wu M.; Shih J.-Y.; Chen K.-Y.; Ho C.-C.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:09:13Z |
Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancer
|
Yang J.C.-H.; Chang Y.-C.; Yu C.-J.; Shih J.-Y.; Lin C.-C.; Chen K.-Y.; Ho C.-C.; WEI-YU LIAO; Yang P.-C.; Chen H.-Y.; Hsu W.-H.; Lin Y.-L.; Lee J.-H.; Lee J.-H.;Lin Y.-L.;Hsu W.-H.;Chen H.-Y.;Chang Y.-C.;Yu C.-J.;Shih J.-Y.;Lin C.-C.;Chen K.-Y.;Ho C.-C.;Wei-Yu Liao;Yang P.-C.;Yang J.C.-H. |
| 臺大學術典藏 |
2020-07-21T06:09:11Z |
EGFR mutation and lobar location of lung adenocarcinoma
|
Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; Chen K.-Y.; WEI-YU LIAO; Shih J.-Y.; Yu S.-L.; Yu C.-J.; Yang P.-C.; Yang T.-Y.; Chang G.-C.; Chen H.-J.; Wu T.-C.; Tseng C.-H.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Ho C.-C.; Hsia T.-C.; Su K.-Y.; Wu M.-F.; Chiu K.-L.; Liu C.-M. |
| 臺大學術典藏 |
2020-07-21T06:09:11Z |
Discordant HER2 Exon 20 mutation status determines a differential sensitivity to Afatinib
|
Liu Y.-N.; Shih J.-Y.; WEI-YU LIAO; Gow C.-H. |
| 臺大學術典藏 |
2020-07-21T06:09:10Z |
Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis
|
Chen L.-Y.;Molina-Vila M.A.;Ruan S.-Y.;Su K.-Y.;Wei-Yu Liao;Yu K.-L.;Ho C.-C.;Shih J.-Y.;Yu C.-J.;Yang J.C.H.;Rosell R.;Yang P.-C.; Chen L.-Y.; Molina-Vila M.A.; Ruan S.-Y.; Su K.-Y.; WEI-YU LIAO; Yu K.-L.; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.H.; Rosell R.; Yang P.-C. |
| 臺大學術典藏 |
2020-07-21T06:09:09Z |
Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib
|
Yu C.-J.; Yang J.C.H.; Yao Z.-H.;Wei-Yu Liao;Ho C.-C.;Chen K.-Y.;Shih J.-Y.;Chen J.-S.;Lin Z.-Z.;Lin C.-C.;Yang J.C.H.;Yu C.-J.; Yao Z.-H.; WEI-YU LIAO; Ho C.-C.; Chen K.-Y.; Shih J.-Y.; Chen J.-S.; Lin Z.-Z.; Lin C.-C. |
| 臺大學術典藏 |
2020-07-21T06:09:09Z |
Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib
|
Chih-Hsin Yang J.; Yu C.-J.; Ho C.-C.;Wei-Yu Liao;Lin C.-A.;Shih J.-Y.;Yu C.-J.;Chih-Hsin Yang J.; Ho C.-C.; WEI-YU LIAO; Lin C.-A.; Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:09:08Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Ho C.-C.;Wei-Yu Liao;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Hsu W.-H.;Su K.-Y.;Chang Y.-L.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; WEI-YU LIAO; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:09:07Z |
Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery
|
Hsu F.-M.; Yang P.-C.; Yang W.-C.;Xiao F.;Shih J.-Y.;Ho C.-C.;Chen Y.-F.;Tseng H.-M.;Chen K.-Y.;Wei-Yu Liao;Yu C.-J.;Yang J.C.-H.;Kuo S.-H.;Cheng J.C.-H.;Yang P.-C.;Hsu F.-M.; Yang W.-C.; Xiao F.; Shih J.-Y.; Ho C.-C.; Chen Y.-F.; Tseng H.-M.; Chen K.-Y.; WEI-YU LIAO; Yu C.-J.; Yang J.C.-H.; Cheng J.C.-H.; Kuo S.-H. |
| 臺大學術典藏 |
2020-07-21T06:09:06Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liang S.-K.;Lee M.-R.;Wei-Yu Liao;Ho C.-C.;Ko J.-C.;Shih J.-Y.; Liang S.-K.; Lee M.-R.; WEI-YU LIAO; Ho C.-C.; Ko J.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:09:06Z |
Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum
|
Shih J.-Y.; Yu C.-J.; Chen K.-Y.; Tsai T.-H.; Ho C.-C.; WEI-YU LIAO; Wei-Yu Liao;Ho C.-C.;Tsai T.-H.;Chen K.-Y.;Shih J.-Y.;Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T06:09:06Z |
Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non–Small-cell Lung Cancer Patients
|
Shih J.-Y.; Ho C.-C.; Wu T.-H.;Hsiue E.H.-C.;Lee J.-H.;Lin C.-C.;Wei-Yu Liao;Ho C.-C.;Shih J.-Y.;Yu C.-J.;Yang J.C.-H.; Wu T.-H.; Hsiue E.H.-C.; Lee J.-H.; Lin C.-C.; WEI-YU LIAO; Yu C.-J.; Yang J.C.-H. |
| 臺大學術典藏 |
2020-07-21T06:09:05Z |
The value of radial endobronchial ultrasound-guided bronchial brushing in peripheral non-squamous non-small cell lung cancer
|
Yu K.-L.; Tsai T.-H.; Ho C.-C.; WEI-YU LIAO; Lin C.-K.; Hsu C.-L.; Shih J.-Y.; Yu K.-L.;Tsai T.-H.;Ho C.-C.;Wei-Yu Liao;Lin C.-K.;Hsu C.-L.;Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:09:04Z |
Consecutive emergence of typical acquired resistance to EGFR tyrosine kinase inhibitors in a patient with metastatic pulmonary squamous cell carcinoma
|
Yu C.-J.; Shih J.-Y.; WEI-YU LIAO; Hsieh M.-S.; Yang C.-Y. |
| 臺大學術典藏 |
2020-07-21T06:09:04Z |
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations
|
Yu C.-J.; Shih J.-Y.; Yang J.C.-H.; Lin Z.-Z.; Lee J.-H.; Chen K.-Y.; Yang C.-Y.; Hsu C.-L.; Ho C.-C.; WEI-YU LIAO; Chen J.-S.; Lin Y.-T. |
| 臺大學術典藏 |
2020-07-21T06:09:03Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Chen K.-Y.; Tsai T.-H.; Ho C.-C.; WEI-YU LIAO; Yang C.-Y.; Yang C.-Y.;Wei-Yu Liao;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yu C.-J.; Yang J.C.-H.; Shih J.-Y.; Lin C.-C.; Lee J.-H.; Hsu W.-H.; Liao B.-C.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C. |
| 臺大學術典藏 |
2020-07-21T05:40:31Z |
Outcomes of cancer therapy administered to treatment-na?ve lung cancer patients in the intensive care unit
|
Chen Y.-F.; Lin J.-W.; Ho C.-C.; CHING-YAO YANG; Chang C.-H.; Huang T.-M.; Chen C.-Y.; Chen K.-Y.; Shih J.-Y.; Yu C.-J.; Chen Y.-F.;Lin J.-W.;Ho C.-C.;Ching-Yao Yang;Chang C.-H.;Huang T.-M.;Chen C.-Y.;Chen K.-Y.;Shih J.-Y.;Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T05:40:30Z |
Miliary pulmonary nodules: An unusual presentation of leptospirosis
|
Chen Y.-H.;Ching-Yao Yang;Shih J.-Y.;Yu C.-J.; Chen Y.-H.; CHING-YAO YANG; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2020-07-21T05:40:29Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.; Lee J.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Ching-Yao Yang;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; CHING-YAO YANG; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H. |
| 臺大學術典藏 |
2020-07-06T07:33:02Z |
Echogenic floating spherules as a sonographic sign of cystic teratoma of mediastinum: Correlation with CT and pathologic findings
|
Shih J.-Y.;Wang H.-C.;Chang Y.-L.;Yeun-Chung Chang;Lee Y.-C.;Yang P.-C.; Shih J.-Y.; Wang H.-C.; Chang Y.-L.; YEUN-CHUNG CHANG; Lee Y.-C.; Yang P.-C. |
| 臺大學術典藏 |
2020-07-01T08:12:36Z |
Identification of a novel biomarker, SEMA5A, for non-small cell lung carcinoma in nonsmoking women
|
Lu T.-P.;Tsai M.-H.;Lee J.-M.;Hsu C.-P.;Chen P.-C.;Lin C.-W.;Shih J.-Y.;Yang P.-C.;Hsiao C.K.;Liang-Chuan Lai;Chuang E.Y.; Lu T.-P.; Tsai M.-H.; Lee J.-M.; Hsu C.-P.; Chen P.-C.; Lin C.-W.; Shih J.-Y.; Yang P.-C.; Hsiao C.K.; LIANG-CHUAN LAI; Chuang E.Y. |
| 臺大學術典藏 |
2020-06-30T08:10:10Z |
Mice deficient in collapsin response mediator protein-1 exhibit impaired long-term potentiation and impaired spatial learning and memory
|
Kang-Yi Su;Chien W.-L.;Fu W.-M.;Yu I.-S.;Huang H.-P.;Huang P.-H.;Lin S.-R.;Shih J.-Y.;Lin Y.-L.;Hsueh Y.-P.;Yang P.-C.;Lin S.-W.; KANG-YI SU; Chien W.-L.; Fu W.-M.; Yu I.-S.; Huang H.-P.; Huang P.-H.; Lin S.-R.; Shih J.-Y.; Lin Y.-L.; Hsueh Y.-P.; Yang P.-C.; Lin S.-W. |
| 臺大學術典藏 |
2020-06-30T08:10:09Z |
Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutations
|
Yuan S. ;Yu S.-L. ;Chen H.-Y. ;Hsu Y.-C. ;Kang-Yi Su ;Chen H.-W. ;Chen C.-Y. ;Yu C.-J. ;Shih J.-Y. ;Chang Y.-L. ;Cheng C.-L. ;Hsu C.-P. ;Hsia J.-Y. ;Lin C.-Y. ;Wu G. ;Liu C.-H. ;Wang C.-D. ;Yang K.-C. ;Chen Y.-W. ;Lai Y.-L. ;Hsu C.-C. ;Lin T.-C. ;Yang T.-Y. ;Chen K.-C. ;Hsu K.-H. ;Chen J.J.W. ;Chang G.-C. ;Li K.-C. ;Yang P.-C.; Yuan S.; Yu S.-L.; Chen H.-Y.; Hsu Y.-C.; KANG-YI SU; Chen H.-W.; Chen C.-Y.; Yu C.-J.; Shih J.-Y.; Chang Y.-L.; Cheng C.-L.; Hsu C.-P.; Hsia J.-Y.; Lin C.-Y.; Wu G.; Liu C.-H.; Wang C.-D.; Yang K.-C.; Chen Y.-W.; Lai Y.-L.; Hsu C.-C.; Lin T.-C.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Chen J.J.W.; Chang G.-C.; Li K.-C.; Yang P.-C. |
| 臺大學術典藏 |
2020-06-30T08:10:09Z |
Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor
|
Chang T.-H. ;Tsai M.-F. ;Kang-Yi Su ;Wu S.-G. ;Huang C.-P. ;Yu S.-L. ;Yu Y.-L. ;Lan C.-C. ;Yang C.-H. ;Lin S.-B. ;Wu C.-P. ;Shih J.-Y. ;Yang P.-C.; Chang T.-H.; Tsai M.-F.; KANG-YI SU; Wu S.-G.; Huang C.-P.; Yu S.-L.; Yu Y.-L.; Lan C.-C.; Yang C.-H.; Lin S.-B.; Wu C.-P.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-06-30T08:10:05Z |
Identification of Five Driver Gene Mutations in Patients with Treatment-Na?ve Lung Adenocarcinoma in Taiwan
|
Hsu K.-H.;Ho C.-C.;Hsia T.-C.;Tseng J.-S.;Kang-Yi Su;Wu M.-F.;Chiu K.-L.;Yang T.-Y.;Chen K.-C.;Ooi H.;Wu T.-C.;Chen H.-J.;Chen H.-Y.;Chang C.-S.;Hsu C.-P.;Hsia J.-Y.;Chuang C.-Y.;Lin C.-H.;Chen J.J.W.;Chen K.-Y.;Liao W.-Y.;Shih J.-Y.;Yu S.-L.;Yu C.-J.;Yang P.-C.;Chang G.-C.; Hsu K.-H.; Ho C.-C.; Hsia T.-C.; Tseng J.-S.; KANG-YI SU; Wu M.-F.; Chiu K.-L.; Yang T.-Y.; Chen K.-C.; Ooi H.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; Chen K.-Y.; Liao W.-Y.; Shih J.-Y.; Yu S.-L.; Yu C.-J.; Yang P.-C.; Chang G.-C. |
| 臺大學術典藏 |
2020-06-30T08:10:03Z |
EGFR mutation and lobar location of lung adenocarcinoma
|
Tseng C.-H.;Chen K.-C.;Hsu K.-H.;Tseng J.-S.;Ho C.-C.;Hsia T.-C.;Kang-Yi Su;Wu M.-F.;Chiu K.-L.;Liu C.-M.;Wu T.-C.;Chen H.-J.;Chen H.-Y.;Chang C.-S.;Hsu C.-P.;Hsia J.-Y.;Chuang C.-Y.;Lin C.-H.;Chen J.J.W.;Chen K.-Y.;Liao W.-Y.;Shih J.-Y.;Yu S.-L.;Yu C.-J.;Yang P.-C.;Yang T.-Y.;Chang G.-C.; Tseng C.-H.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Ho C.-C.; Hsia T.-C.; KANG-YI SU; Wu M.-F.; Chiu K.-L.; Liu C.-M.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; Chen K.-Y.; Liao W.-Y.; Shih J.-Y.; Yu S.-L.; Yu C.-J.; Yang P.-C.; Yang T.-Y.; Chang G.-C. |
| 臺大學術典藏 |
2020-06-30T08:09:57Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Ho C.-C.;Liao W.-Y.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Hsu W.-H.;Kang-Yi Su;Chang Y.-L.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; KANG-YI SU; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2020-06-30T08:09:56Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Lin C.-C.;Shih J.-Y.;Yu C.-J.;Ho C.-C.;Liao W.-Y.;Lee J.-H.;Tsai T.-H.;Kang-Yi Su;Hsieh M.-S.;Chang Y.-L.;Bai Y.-Y.;Huang D.D.-R.;Thress K.S.;Yang J.C.-H.; Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; Lee J.-H.; Tsai T.-H.; KANG-YI SU; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H. |
| 臺大學術典藏 |
2020-06-30T08:09:52Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Kang-Yi Su;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; KANG-YI SU; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-06-30T08:09:51Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Kang-Yi Su;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; KANG-YI SU; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-06-22T07:37:15Z |
Mice deficient in collapsin response mediator protein-1 exhibit impaired long-term potentiation and impaired spatial learning and memory
|
Su K.-Y.;Chien W.-L.;Fu W.-M.;Yu I.-S.;Huang H.-P.;Huang P.-H.;Lin S.-R.;Shih J.-Y.;Lin Y.-L.;Hsueh Y.-P.;Yang P.-C.;Shu-Wha Lin; Su K.-Y.; Chien W.-L.; Fu W.-M.; Yu I.-S.; Huang H.-P.; Huang P.-H.; Lin S.-R.; Shih J.-Y.; Lin Y.-L.; Hsueh Y.-P.; Yang P.-C.; SHU-WHA LIN |
| 臺大學術典藏 |
2020-06-17T03:01:51Z |
Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor
|
Chang T.-H. ;Tsai M.-F. ;Su K.-Y. ;Wu S.-G. ;Huang C.-P. ;Sung-Liang Yu ;Yu Y.-L. ;Lan C.-C. ;Yang C.-H. ;Lin S.-B. ;Wu C.-P. ;Shih J.-Y. ;Yang P.-C.; Chang T.-H.; Tsai M.-F.; Su K.-Y.; Wu S.-G.; Huang C.-P.; SUNG-LIANG YU; Yu Y.-L.; Lan C.-C.; Yang C.-H.; Lin S.-B.; Wu C.-P.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-06-17T03:01:49Z |
Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutations
|
Yuan S. ;Sung-Liang Yu ;Chen H.-Y. ;Hsu Y.-C. ;Su K.-Y. ;Chen H.-W. ;Chen C.-Y. ;Yu C.-J. ;Shih J.-Y. ;Chang Y.-L. ;Cheng C.-L. ;Hsu C.-P. ;Hsia J.-Y. ;Lin C.-Y. ;Wu G. ;Liu C.-H. ;Wang C.-D. ;Yang K.-C. ;Chen Y.-W. ;Lai Y.-L. ;Hsu C.-C. ;Lin T.-C. ;Yang T.-Y. ;Chen K.-C. ;Hsu K.-H. ;Chen J.J.W. ;Chang G.-C. ;Li K.-C. ;Yang P.-C.; Yuan S.; SUNG-LIANG YU; Chen H.-Y.; Hsu Y.-C.; Su K.-Y.; Chen H.-W.; Chen C.-Y.; Yu C.-J.; Shih J.-Y.; Chang Y.-L.; Cheng C.-L.; Hsu C.-P.; Hsia J.-Y.; Lin C.-Y.; Wu G.; Liu C.-H.; Wang C.-D.; Yang K.-C.; Chen Y.-W.; Lai Y.-L.; Hsu C.-C.; Lin T.-C.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Chen J.J.W.; Chang G.-C.; Li K.-C.; Yang P.-C. |
| 臺大學術典藏 |
2020-06-17T03:01:31Z |
Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C
|
Chang T.-H.;Tsai M.-F.;Gow C.-H.;Wu S.-G.;Liu Y.-N.;Chang Y.-L.;Sung-Liang Yu;Tsai H.-C.;Lin S.-W.;Chen Y.-W.;Kuo P.-Y.;Yang P.-C.;Shih J.-Y.; Chang T.-H.; Tsai M.-F.; Gow C.-H.; Wu S.-G.; Liu Y.-N.; Chang Y.-L.; SUNG-LIANG YU; Tsai H.-C.; Lin S.-W.; Chen Y.-W.; Kuo P.-Y.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-05-26T09:27:27Z |
Predictive factors of gefitinib antitumor activity in East Asian advanced non-small cell lung cancer patients
|
Chang G.-C;Tsai C.-M;Chen K.-C;Yu C.-J;Shih J.-Y;Yang T.-Y;Lin C.-P;Hsu J.-Y;Chiu C.-H;Perng R.-P;Yang P.-C;Chih-Hsin Yang; Chang G.-C; Tsai C.-M; Chen K.-C; Yu C.-J; Shih J.-Y; Yang T.-Y; Lin C.-P; Hsu J.-Y; Chiu C.-H; Perng R.-P; Yang P.-C; CHIH-HSIN YANG |
| 臺大學術典藏 |
2020-05-26T09:27:27Z |
Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer
|
Shih J.-Y;Gow C.-H;Yu C.-J;Chih-Hsin Yang;Chang Y.-L;Tsai M.-F;Hsu Y.-C;Chen K.-Y;Su W.-P;Yang P.-C.; Shih J.-Y; Gow C.-H; Yu C.-J; CHIH-HSIN YANG; Chang Y.-L; Tsai M.-F; Hsu Y.-C; Chen K.-Y; Su W.-P; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:27Z |
Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status
|
Su W.-P;Chih-Hsin Yang;Yu C.-J;Shih J.-Y;Hsu C;Yang P.-C.; Su W.-P; CHIH-HSIN YANG; Yu C.-J; Shih J.-Y; Hsu C; Yang P.-C. |
